Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | NPFFR1 | Q9GZQ6 | 3/20 | 0.41 |
| ▸ | NPFFR2 | Q9Y5X5 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL111119 | 1.00 | ALDH1A1 (0.46) | ALDH1A1KDM4EL3MBTL1SMN1; SMN2RAB9A | |
| SCHEMBL648157 | 1.00 | ALDH1A1 (0.46) | ALDH1A1KDM4EL3MBTL1SMN1; SMN2RAB9A | |
| SCHEMBL1304437 | 0.86 | SMN1; SMN2 (0.47) | ALDH1A1KDM4EL3MBTL1SMN1; SMN2RAB9A | |
| SCHEMBL1304439 | 0.86 | SMN1; SMN2 (0.47) | ALDH1A1KDM4EL3MBTL1SMN1; SMN2RAB9A | |
| SCHEMBL2726909 | 0.86 | SMN1; SMN2 (0.47) | ALDH1A1KDM4EL3MBTL1SMN1; SMN2RAB9A | |
| SCHEMBL7820864 | 0.82 | ALDH1A1 (0.39) | ALDH1A1KDM4ESMN1; SMN2RAB9ANPFFR1 | |
| SCHEMBL7820867 | 0.82 | ALDH1A1 (0.39) | ALDH1A1KDM4ESMN1; SMN2RAB9ANPFFR1 | |
| SCHEMBL1937076 | 0.81 | ALDH1A1 (0.50) | ALDH1A1KDM4EL3MBTL1SMN1; SMN2RAB9A | |
| SCHEMBL2166114 | 0.81 | ALDH1A1 (0.50) | ALDH1A1KDM4EL3MBTL1SMN1; SMN2RAB9A | |
| SCHEMBL1937074 | 0.81 | ALDH1A1 (0.50) | ALDH1A1KDM4EL3MBTL1SMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118894789-A | Method for continuously synthesizing alpha-chloro oxime | 苏利(宁夏)新材料科技有限公司 | 2024-11-05 | — | — | CN | disclosed |
| WO-2024120137-A1 | SUBSTITUTED BENZAMIDE ISOXAZOLINE DERIVATIVE OR AGROCHEMICALLY ACCEPTABLE SALT THEREOF, COMPOSITION, AND USE THEREOF | 海利尔药业集团股份有限公司 | 2024-06-13 | — | — | WO | disclosed |
| CN-117777045-A | Substituted benzamide isoxazoline derivative or salt, composition and application thereof as pesticide acceptable | 青岛蓝晶雨生物科技有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-116396235-B | Synthetic method of isoxazoline insecticide and intermediate thereof | 宁波大学科学技术学院 | 2024-01-05 | — | — | CN | disclosed |
| CN-112552252-B | Preparation method of fluororalrana intermediate | 浙江美诺华药物化学有限公司 | 2024-01-02 | — | — | CN | disclosed |
| CN-115785017-B | Substituted benzamide isoxazoline derivative or salt, composition and application thereof as pesticide acceptable | 海利尔药业集团股份有限公司 | 2023-12-08 | — | — | CN | disclosed |
| US-20230355590-A1 | ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE | NISSAN CHEMICAL CORPORATION (JP) | 2023-11-09 | — | — | US | disclosed |
| CN-113563322-B | Substituted benzamide isoxazoline derivative or salt acceptable as pesticide, composition and application thereof | 海利尔药业集团股份有限公司 | 2023-07-07 | — | — | CN | disclosed |
| CN-116396235-A | Synthetic method of isoxazoline insecticide and intermediate thereof | 宁波大学科学技术学院 | 2023-07-07 | — | — | CN | disclosed |
| CN-113582987-B | Substituted benzamide isoxazoline derivative or salt acceptable as pesticide, composition and application thereof | 海利尔药业集团股份有限公司 | 2023-06-30 | — | — | CN | disclosed |
| US-20090312330-A1 | ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-12-17 | — | — | US | disclosed |
| WO-2009080250-A2 | INSECTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2009-07-02 | — | — | WO | disclosed |
| WO-2009049846-A1 | INSECTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2009-04-23 | — | — | WO | disclosed |
| EP-1932836-A1 | ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND HARMFUL ORGANISM-CONTROLLING AGENT | Nissan Chemical Industries, Ltd. (JP) | 2008-06-18 | — | — | EP | disclosed |
| US-20070066617-A1 | Insecticidal and acaricidal activity for many agricultural insect pests, spider mites; endo- or ecto-parasiticide for mammals or birds; veterinary medicine; environmentally friendly | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-03-22 | — | — | US | disclosed |
| EP-0799226-B1 | TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 2001-02-07 | — | — | EP | disclosed |
| US-5972951-A | Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists | SMITHKLINE BEECHAM PLC (GB) | 1999-10-26 | — | — | US | disclosed |
| CN-1175256-A | tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists | SMITHKLINE BEECHAM PLC (GB) | 1998-03-04 | — | — | CN | disclosed |
| EP-0799226-A1 | TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1997-10-08 | — | — | EP | disclosed |
| WO-1996019477-A1 | TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1996-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355590-A1 | ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE | HDAC7, ACHE, BRDT | ALDH1A1 865/4885KDM4E 1334/4885L3MBTL1 2698/4885 |
| US-20090312330-A1 | ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE | ATM, CHRM1, NAT1 | ALDH1A1 806/4885KDM4E 3394/4885L3MBTL1 818/4885 |
| US-20070066617-A1 | Insecticidal and acaricidal activity for many agricultural insect pests, spider mites; endo- or ecto-parasiticide for mammals or birds; veterinary medicine; environmentally friendly | CHRM1, DDT, ATM | ALDH1A1 1359/4885KDM4E 3630/4885L3MBTL1 200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.